Research Consensus
What does the research actually say? Each page below synthesizes findings from peer-reviewed studies into balanced, evidence-weighted summaries.
Medical Cannabis & Drug Interactions
Meta-analysis of 30 trials found cannabinoids significantly outperformed older anti-nausea drugs for chemotherapy, with nearly half of 1,138 patients preferring cannabinoids despite more side effects
Cannabis Addiction
Meta-analysis of 28+ twin studies found genetics explained 40-48% of cannabis initiation and 51-59% of problematic use, with environment more influential for initiation
Cannabis and Your Brain
Meta-analysis of 20 fMRI studies found cannabis users show altered brain activation patterns, with different changes in adults (temporal/frontal regions) versus adolescents (parietal/putamen)
Youth Cannabis Exposure
Across 22 longitudinal cohorts, cannabis use was linked to about 29 percent higher odds of later depression, with exposure measures often weak and overall bias rated medium
CBD Research
Meta-analysis of 11 RCTs finding selective cannabinoids provide a small but significant reduction in neuropathic pain (-0
Cannabis Harm Reduction
Mega-analysis of 400 IV THC infusions found psychosis-like symptoms in 45% of healthy volunteers, with effects increasing with dose and decreasing with regular cannabis use history
Cannabis and Mental Health
Across 22 longitudinal cohorts, cannabis use was linked to about 29 percent higher odds of later depression, with exposure measures often weak and overall bias rated medium
Cannabis and Cognition
Meta-analysis found schizophrenia patients who used cannabis had better cognitive performance than non-using patients, suggesting a different pathway to psychosis
Cannabis and Pain
Meta-analysis of 11 RCTs finding selective cannabinoids provide a small but significant reduction in neuropathic pain (-0
Cannabis Law and Regulation
Meta-analysis of 18,000+ paired samples found oral fluid THC tests detect recent cannabis use well but are unreliable for predicting whether blood THC exceeds legal driving limits
Cannabis and Psychosis
Meta-analysis found schizophrenia patients who used cannabis had better cognitive performance than non-using patients, suggesting a different pathway to psychosis
Cannabis and Pregnancy
Meta-analysis of 57 studies found prenatal cannabis exposure increased risks of preterm birth (68%), low birth weight (160%), and NICU admission (151%), with limited cognitive effects beyond attention problems
Cannabis and Inflammation
Meta-analysis of 18 trials shows CB1 receptor blockers consistently caused diarrhea and GI symptoms, suggesting potential repurposing for constipation-predominant IBS if psychiatric side effects can be avoided
Cannabis Effects and Pharmacology
Mega-analysis of 400 IV THC infusions found psychosis-like symptoms in 45% of healthy volunteers, with effects increasing with dose and decreasing with regular cannabis use history
Cannabis and Driving
Meta-analysis of 9 studies found cannabis nearly doubles motor vehicle crash risk (OR 1
Cannabis and Cancer
Meta-analysis of 30 trials found cannabinoids significantly outperformed older anti-nausea drugs for chemotherapy, with nearly half of 1,138 patients preferring cannabinoids despite more side effects
Cannabis and Anxiety
THC produces a biphasic dose-response on anxiety: low doses (2.5-5mg) reduce anxiety through CB1-mediated dampening of amygdala reactivity, while higher doses (>10mg) increase anxiety, sometimes to the level of panic attacks, through the same receptor system at higher occupancy
Cannabis Cessation Interventions
First meta-analysis of cannabis withdrawal prevalence: 47% of regular/dependent users experienced clinically significant withdrawal across 23 studies and 27,000+ participants
Cannabis Cessation Outcomes
First meta-analysis of cannabis withdrawal prevalence: 47% of regular/dependent users experienced clinically significant withdrawal across 23 studies and 27,000+ participants
Cannabis and Cardiovascular Health
Largest-ever meta-analysis (183M patients) found cannabis use significantly associated with stroke risk but not heart attack risk — though observational data can't prove causation
Sex Differences in Cannabis
Meta-analysis of 45 fMRI studies (2,702 youth) found cannabis users showed altered activation in prefrontal and cingulate regions, varying by sex, severity, and psychiatric comorbidity
Cannabis and Epilepsy
Meta-analysis of 550 patients found CBD reduced seizures by ~20 percentage points in severe childhood epilepsies
Cannabis Genetics
Meta-analysis of 28+ twin studies found genetics explained 40-48% of cannabis initiation and 51-59% of problematic use, with environment more influential for initiation
Cannabis and Depression
Across 22 longitudinal cohorts, cannabis use was linked to about 29 percent higher odds of later depression, with exposure measures often weak and overall bias rated medium
Cannabis Consumption Methods
Comprehensive review found synthetic cannabinoids are 2-100x more potent than THC, producing severe adverse effects including psychosis, kidney failure, and cardiac events
Synthetic Cannabinoids
Comprehensive review found synthetic cannabinoids are 2-100x more potent than THC, producing severe adverse effects including psychosis, kidney failure, and cardiac events
Cannabis Withdrawal Syndrome
Cannabis withdrawal affects approximately 47% of regular/dependent users — confirmed by the first meta-analysis pooling 23 studies with 27,461 participants
Cannabis and Drug Interactions
Meta-analysis of pivotal trials found CBD has independent anti-seizure effects, though the benefit is amplified by interaction with clobazam
Cannabis and Potency
Meta-analysis of 372 participants found THC's brain effects are dose-dependent and track with CB1 receptor density across regions
Cannabis and Sleep
Recreational cannabis use is associated with worse sleep outcomes at the population level, including poorer sleep quality, abnormal sleep duration, and increased insomnia symptoms.
Cannabis and Appetite
Review revealing that the endocannabinoid system regulates metabolism throughout the body via peripheral CB1 receptors, opening new treatment avenues after rimonabant's psychiatric side effects ended its use
Cannabis and Respiratory Health
Meta-analysis of 8 studies found cannabis users had 31% higher odds of asthma diagnosis than non-users, with consistent results across sensitivity analyses
Cannabis and Dopamine
A specific AKT1 gene variant determined whether THC impaired psychomotor control, with carriers showing increased errors and reduced brain activation in a motor control region
Cannabis and Seniors
Meta-analysis of 58 RCTs in adults 50+ found cannabinoid medicines increase common side effects dose-dependently but do not significantly increase serious adverse events, withdrawals, or deaths
THC Research
Meta-analysis of 13 studies found converging experimental and observational evidence that cannabis use causes paranoid symptoms, with THC-dominant products producing the strongest effects
Cannabis and PTSD
A Lancet meta-analysis of 83 studies found scarce evidence that cannabinoids help depression, anxiety, PTSD, or other mental disorders, with THC products doubling adverse event rates versus placebo
Cannabis Health Risks
Meta-analysis of 13 studies found prenatal cannabis exposure significantly increased odds of small-for-gestational-age and low birth weight outcomes
Cannabis and Performance
Rigorous crossover trial found CBD at 50 mg and 300 mg did not improve or impair running performance, mood, or perceived exertion in trained athletes
Cannabis Policy
Analysis of 1,695 poison control reports found child cannabis exposures requiring medical attention increased significantly after California legalization, with 83
Endocannabinoid System
Cannabis and Substance Use
In 526 young adults tracked through emerging adulthood, cannabis use increases predicted more binge drinking at ages 18–21 but less binge drinking by ages 24–25, revealing an age-dependent relationship
Cannabis and Exercise
Rigorous crossover trial found CBD at 50 mg and 300 mg did not improve or impair running performance, mood, or perceived exertion in trained athletes
Cannabis and Adolescents
A 15-year French survey of 150,000+ teens found that while fewer adolescents use cannabis today, those who do show much stronger associations with suicidal thoughts and antidepressant use than teen users did in 2008
Cannabis Public Health
Meta-analysis of 220,362 adolescents across 47 countries found 7% global cannabis prevalence, with boys and high-income countries showing higher rates and Latin America leading regionally
Cannabis and Alcohol
An analysis of 8 million+ alcohol screenings in California found that cannabis legalization was associated with declining heavy drinking in younger adults (21–34) but not in older adults, suggesting age shapes the substitution effect
Cannabis and the Workplace
National survey of 46,499 workers found a clear dose-response: mild CUD increased work-skipping 1
Cannabis Use Disorder
A machine learning model using just five factors — sex, delinquency, and three personality traits — predicted cannabis use disorder within 5 years of first use, validated across three datasets
Neuroprotection and Cannabis
Cannabis and Tobacco
PATH Study analysis of 8,218 cigarette smokers found cannabis co-use (reported by 36%) was associated with 19% lower odds of quitting smoking and 25% lower odds of quitting all combustible tobacco
Cannabis Pharmacology
A rigorous crossover trial found CBD had no effect on brain excitability or sedation at either low or high doses, suggesting its anti-epileptic benefits may come from drug interactions rather than direct activity
Cannabis and the Gut
Analysis of 248 million ER encounters found 134,059 CHS visits from 2016-2024, primarily in young adults (mean age 32), with steady 13
Cannabis and Vaping
Among 157,500 California students, 75% had heard about vaping lung injuries but only 11% correctly identified cannabis vapes as the cause — most blamed nicotine, highlighting a critical gap in health communication